Lupin's Aurangabad facility receives EIR from USFDA; stock up 3.6%

The inspection for the facility was carried out by the USFDA between February 10, 2020 and February 14, 2020 and concluded with no observations.

from India Infoline News Service https://ift.tt/3aQBxWY